18 results on '"Baldini, Luca"'
Search Results
2. A phase II study of bendamustine in combination with rituximab as initial treatment for patients with indolent non-follicular non-Hodgkin lymphoma
3. Bendamustine in relapsed/refractory multiple myeloma: the “real-life” side of the moon
4. Panobinostat in combination with bortezomib and dexamethasone as induction therapy in patients with multiple myeloma, candidates for autologous transplant
5. Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly “fit” patients with diffuse large B-cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi
6. Low dose alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia
7. Radiation therapy improves treatment outcome in patients with diffuse large B-cell lymphoma
8. Long term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with PROMECE-CYTABOM plus involved-field radiation therapy: a study by the Gruppo Italiano Studio Linfomi
9. Prospective Study of Indolent Non-follicular Non-Hodgkin's Lymphoma: Validation of Gruppo Italiano Per Lo Studio Dei Linfomi ( GISL ) Prognostic Criteria for Watch and Wait Policy
10. Soluble Cytokine Levels Correlate with the Activity and Clinical Stage of Hodgkin's Disease at Diagnosis
11. OPP-EBV-CAD Regimen as Salvage Treatment in Advanced Refractory or Resistant Multiple Myeloma
12. Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi.
13. Structure and Function of VLA Integrins: Differential Expression in B-Cell Leukemia/Lymphoma
14. A CooDerative Studv on ProMACE-dytaBOM in Aggressive Non-Hodgkin's Lymphomas
15. Pamidronate versus observation in asymptomatic myeloma: final results with long-term follow-up of a randomized study.
16. Long term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with PROMECE-CYTABOM plus involved-field radiation therapy: a study by the Gruppo Italiano Studio Linfomi.
17. Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients.
18. Prospective Study of Indolent Non-follicular Non-Hodgkin's Lymphoma: Validation of Gruppo Italiano Per Lo Studio Dei Linfomi (GISL) Prognostic Criteria of Watch and Wait Policy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.